From Patient to Advocate: One Woman's Journey Through Type 1 Diabetes and Clinical Trials

Alecia Wesner was diagnosed with Type 1 diabetes as a kindergartener in 1979. Decades later, she's helping shape the future of T1D research by serving on a clinical trial advisory council.

News report — unverified, pending corroboration

Evidence label explains the kind of source behind this article (for example peer-reviewed literature vs community video). It is not medical advice.

diagnosisscreeningstaging

Key takeaways

Type 1 diabetes can develop quickly in young children, sometimes with subtle early warning signs like extreme thirst
A diagnosis in the late 1970s meant hospitalization and intensive family training—a very different experience from today's approach
Clinical trial participation offers people with T1D a way to contribute to research that may help future generations
Patient voices matter in shaping how clinical trials are designed and conducted

A Summer Diagnosis

Alecia Wesner was six years old, having just finished kindergarten, when the signs of Type 1 diabetes appeared. It was summer in suburban Philadelphia, and she remembers being thirsty—constantly thirsty. On one day at a neighbor's house, she drank an entire quart of iced tea within minutes. That moment caught her parents' attention and prompted a call to her pediatrician.

What followed was a hospital admission, blood draws, and a week and a half stay in a children's ward where her parents learned to manage her new diagnosis. She practiced injecting insulin on an orange while arts and crafts filled her hospital days. It was 1979, and the experience was isolating—she called her parents on a pay phone each night, crying and asking to come home.

From Patient to Clinical Trial Participant

Decades after her diagnosis, Wesner took on a new role in the T1D community. She became a Clinical Trial Education Volunteer and a member of a Participant Advisory Council (PAC), helping to shape how clinical trials are designed and conducted. Her lived experience with Type 1 diabetes—from childhood diagnosis through adulthood—brought valuable perspective to this work.

Wesner's involvement reflects a growing recognition that people living with T1D have essential insights about research. Clinical trial advisory councils bring patient voices into the planning process, ensuring that studies address questions that matter most to the community.

Why Patient Voices Matter in Research

Participating in clinical trials and supporting trial education is one way people with T1D can contribute to research aimed at helping others. Wesner's journey—from a frightened child in a hospital to an advocate shaping the future of T1D research—shows how lived experience can fuel meaningful engagement in science.

As a long-time Breakthrough T1D supporter, Wesner has watched the field evolve. Her participation in clinical trials, combined with her role advising researchers, represents a model where patients are partners in the quest to better understand and treat Type 1 diabetes.

Evidence label

Origin: breakthrought1d.org (News report). Evidence: News report — unverified, pending corroboration. Type1Cure is an information and intelligence hub, not a medical advice service. This article summarizes published research and does not provide diagnosis, treatment, or personal medical guidance. Always talk to your own care team before changing anything about your Type 1 diabetes management.

Type1Cure is an information and intelligence hub, not a medical advice service. This article summarizes published research and does not provide diagnosis, treatment, or personal medical guidance. Always talk to your own care team before changing anything about your Type 1 diabetes management.

More evidence-labeled coverage across the Type1Cure library.